Advanced Medical Isotope ROE 2013-2024 | RDGL
Current and historical return on equity (ROE) values for Advanced Medical Isotope (RDGL) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Advanced Medical Isotope ROE - Return on Equity Historical Data |
| Date |
TTM Net Income |
Shareholder's Equity |
Return on Equity |
| 2024-06-30 |
$-0.00B |
$0.00B |
-320.00% |
| 2024-03-31 |
$-0.00B |
$0.00B |
-320.00% |
| 2023-12-31 |
$-0.00B |
$0.00B |
-240.00% |
| 2023-09-30 |
$-0.00B |
$0.00B |
-200.00% |
| 2023-06-30 |
$-0.00B |
$0.00B |
-114.29% |
| 2023-03-31 |
$-0.00B |
$0.00B |
-133.33% |
| 2022-12-31 |
$-0.00B |
$0.00B |
-200.00% |
| 2022-09-30 |
$-0.00B |
$0.00B |
-160.00% |
| 2022-06-30 |
$-0.00B |
$0.00B |
-200.00% |
| 2022-03-31 |
$-0.00B |
$0.00B |
-240.00% |
| 2021-12-31 |
$-0.00B |
$0.00B |
-133.33% |
| 2021-09-30 |
$-0.00B |
$0.00B |
-160.00% |
| 2021-06-30 |
$-0.00B |
$0.00B |
-266.67% |
| 2021-03-31 |
$0.00B |
$0.00B |
nan% |
| 2020-12-31 |
$0.00B |
$0.00B |
0.00% |
| 2020-09-30 |
$-0.00B |
$-0.00B |
100.00% |
| 2020-06-30 |
$-0.00B |
$-0.00B |
200.00% |
| 2020-03-31 |
$-0.00B |
$-0.00B |
200.00% |
| 2019-12-31 |
$-0.00B |
$-0.00B |
200.00% |
| 2019-09-30 |
$0.03B |
$-0.00B |
-2500.00% |
| 2019-06-30 |
$-0.00B |
$-0.00B |
10.53% |
| 2019-03-31 |
$-0.01B |
$-0.00B |
58.33% |
| 2018-12-31 |
$-0.01B |
$-0.00B |
61.54% |
| 2018-09-30 |
$-0.04B |
$-0.04B |
269.09% |
| 2018-06-30 |
$-0.01B |
$-0.01B |
200.00% |
| 2018-03-31 |
$-0.01B |
$-0.01B |
200.00% |
| 2017-12-31 |
$-0.01B |
$-0.00B |
200.00% |
| 2017-09-30 |
$-0.00B |
$-0.00B |
123.08% |
| 2017-06-30 |
$-0.00B |
$-0.00B |
61.54% |
| 2017-03-31 |
$-0.00B |
$-0.00B |
106.67% |
| 2016-12-31 |
$-0.01B |
$-0.00B |
153.85% |
| 2016-09-30 |
$-0.01B |
$-0.00B |
109.09% |
| 2016-06-30 |
$-0.01B |
$-0.01B |
126.32% |
| 2016-03-31 |
$-0.00B |
$-0.01B |
8.16% |
| 2015-12-31 |
$0.01B |
$-0.01B |
-50.00% |
| 2015-09-30 |
$-0.01B |
$-0.01B |
54.55% |
| 2015-06-30 |
$-0.01B |
$-0.02B |
42.42% |
| 2015-03-31 |
$-0.02B |
$-0.02B |
100.00% |
| 2014-12-31 |
$-0.02B |
$-0.02B |
150.00% |
| 2014-09-30 |
$-0.00B |
$-0.01B |
43.24% |
| 2014-06-30 |
$-0.00B |
$-0.01B |
44.44% |
| 2014-03-31 |
$-0.00B |
$-0.01B |
47.06% |
| 2013-12-31 |
$-0.00B |
$-0.01B |
48.48% |
| 2013-09-30 |
$-0.01B |
$-0.01B |
82.35% |
| 2013-06-30 |
$-0.01B |
$-0.01B |
123.08% |
| 2013-03-31 |
$-0.01B |
$-0.01B |
177.78% |
| 2012-12-31 |
$-0.01B |
$-0.01B |
320.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Finance |
Finance - SBIC & Commercial |
$0.049B |
$0.000B |
|
Vivos Inc. is a late stage development company. It engaged primarily in the development of brachytherapy devices for therapeutic applications. Vivos Inc., formerly known as Advanced Medical Isotope Corporation, is based in Richland, Washington.
|
